Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Glad it was helpful!
ANDA for generics - no clinical trials needed.
Good stuff - a few years down the road their generics could fund considerable R&D.
Percocet - anyone have annual sales figures?
That was a tough weekend! Feeling disappointed about the time frame, but overall relieved at the info presented in the CC. Keeping all of my shares and wishing I had some funds to grab some of the shares on sale. The delayed-effect problem certainly seems solvable and unrelated to the tech.
Anyone have a guess regarding the study methodology that might satisfy the FDA concern assuming it is not repairable with labeling and instructions?
Strange
I was traveling today and missed the CC. Saw the drop when I got home and assumed there was some bad news. Just read the transcript and . . . everything looks great! Seriously more excited today than yesterday.
Excited here too. Could be a fun week.
With the HAL study results and the continued cash flow coming in from the generics, there is no reason not to sit and be patient here. I am sure there will be flipping opportunities along the way for those who like their action a bit more fast paced, but I am happy to sit and watch for a couple more years.
See Aqua's post below
OK, I just hope that they stop releasing positive PR's :)
An opiate primer: This will be old news for veteran longs, but I thought I would provide a brief tutorial for new investors. This information is somewhat redundant with the diagrams provided above, but I hope to provide more detail for those unfamiliar with receptor theory. I have seen a couple posts on this message board, and many on other message boards that, that included some inaccurate statements.
Opiates, which include morphine and codeine and come from the opium poppy, remain our best pain killers (analgesics). Opioids include morphine-like drugs that are produced in a laboratory. Examples include oxycodone, fentanyl, and hydrocodone.
In the central nervous system, these drugs essentially work in the same way. They substitute for naturally occurring chemical messengers and affect cells at structures called receptors. Opioids fit into and activate opioid receptors. A drug that activates a receptor is known as an agonist. A nice analogy is that the opiate molecule (agonist) functions as a key that fits into a receptor. The receptor functions as a lock. There is a nice diagram of this action near the top of this message board. When a receptor is activated, cell activity is altered. The practical result of this receptor activation is a number of drug effects including analgesia. This is why we have prescription opiates. Now all drugs have multiple effects, and another prevalent effect of opiates is that they increase the presence of a chemical messenger called Dopamine in a series of structures called the Dopaminergic Reward Pathway. When this pathway is stimulated, a euphoric effect (rush, buzz, high, etc) results. Drug developers have not yet been able to design an opiate that produces effective analgesia without also producing euphoric effects.
A quick search of the news will demonstrate that rates of prescription opiate abuse have increased dramatically. Prescription opiates also likely function as “gateway drugs” for heroin use. Interestingly, the recreational demand for prescription opiates is so high, that heroin is now dirt cheap in comparison. One more important thing – by crushing up an oral opioid, one can alter the method of administration resulting in a stronger euphoric effect by getting more drug quickly to the central nervous system. This sets the stage for the development of abuse-resistant technology.
Other drugs, known as antagonists, work by blocking receptor sites instead of activating them. Opiate antagonists, such as naltrexone, actually prevent opiates from affecting cells. They can save a user from overdose, or even cause instant withdrawal symptoms in someone who is opioid-dependent. If an opiate and an opiate antagonist are administered at the same time, the antagonist blocks the effects of the opiate.
Elite’s technology involves packaging an agonist and antagonist together in the same capsule. If the drug is administered orally as prescribed the agonist is absorbed and will affect opiate receptors. The antagonist will not be released and has no effect. However, if the capsule is altered chemically or mechanically in hopes if providing rapid delivery of the opioid, the antagonist will be released, cancelling out the effects of the agonist. So, as far as value as a recreational drug goes, the user is likely to look elsewhere.
Listen to the CC and decide for yourself if our enthusiasm has merit.
Looks like the big discounts are drying up. It kind of hurt to see those prices and not be in a position to grab a few. But then again, I didn't sell one share. That is what would have really hurt in a few weeks.
No worries here either. Just for fun, look at the 2009 data for JAZZ. There were certainly 1-day price drops larger than we had today as that stock climbed into the dollars for good.
Just bought a little more. Wish I could do more than a little.
This is a lot more fun now that a 10% gain is worth more than a cent :) Congratulations to all my fellow longs.
What a great week, and it looks like March will be a lot of fun. Thanks to all who post such great research on the board. What PPS do folks think would make a reverse split unnecessary? I'm not afraid of it, and fully understand the conditions NH stated would be in place before such a move may be considered. And with all of the recent attention and likely good news on the horizon, I wonder if a split may quickly become unnecessary. BTW I am averaged in at 0.13 and plan to stick around for a couple more years.
I love the smell of ELTP in the morning.
Probably not healthy for me to just sit and watch the computer all day - but can't pull away! Been holding since 0.13. Tempted to take off a nibble, but that nibble may be worth several feasts before too long. Congratulations everyone!
Perfect morning news! Looks like it will be a fun week.
Just for fun, I'll add my voice to the speculation. I am long on ELTP; I have held for 3 years and have no problem holding for many more. Unless earnings are a grand slam, I expect a temporary dip. Some recent buyers will sell on the news, good or bad. It will recover soon enough. I would not be surprised if 2014 becomes an optical isomer of 2008. I have no formal training in investing, but I do have a graduate degree in psychopharmacology and like what I see here.
Never knew buying and holding could be so exciting.
Looks like another day in which I will accomplish little work. Going to go make some popcorn.
The only other time I enjoyed a run like this was with EGT in 2012. The difference was that stock was getting pumped like crazy and there was never as much potential as we have here. Through nothing but dumb luck, I sold most of my position right before the reverse split. I put it all in ELTP. Been waiting since for a week like this, and I believe the best is yet to come.
A fun day indeed. Been lurking awhile and holding for a few years. Will hold for a few more. Congratulations to all the patient folks on here.